Latest Funding News

Rio Tinto has completed due diligence on Calix’s Zesty Green Iron Demonstration Project, unlocking an initial $3 million investment and moving the venture closer to commercial reality.

Resolute Mining’s updated Definitive Feasibility Study for the Doropo Gold Project reveals a 55% increase in ore reserves, a longer mine life, and robust financial returns, positioning the project as a key growth driver.

Biome Australia has initiated its first human clinical trial for the proprietary probiotic strain Lactobacillus plantarum BMB18, aiming to validate its benefits for digestive and mood-related symptoms.

AusQuest and South32 have extended their Strategic Alliance Agreement for two more years, securing continued funding and collaboration on Australian copper and zinc projects. South32 will fund exploration to advance projects to drill-ready status and can earn up to 80% interest through staged investments.

Ore Resources Ltd has identified 10 new broad gold targets and 18 gold-in-soil anomaly zones at its Randalls South tenements, setting the stage for focused exploration in 2026.

Vection Technologies reports a record quarter-to-date cash intake of approximately $14 million and a robust $50 million forward pipeline, underscoring strong momentum across defence, AI, healthcare, and retail sectors.

Group One Capital has finalized a structured funding facility for the 107-unit Ahlie residential development in Canberra, setting the stage for milestone-driven revenue of up to $6 million over the project lifecycle.

Rent.com.au has locked in up to $5.5 million in growth capital by underwriting the exercise of its remaining listed options, positioning the company for accelerated profitability and expansion of its RentBond® loan book.

Tasman Resources has completed the second tranche of its $2 million share placement, issuing 92 million shares and raising $1.15 million before costs. The company confirms full compliance with regulatory requirements in its updated cleansing notice.

Xstate Resources has launched a prospectus offering nearly 97 million free attaching options to placement participants and contractors, alongside a nominal cleansing offer to remove trading restrictions on recent share issuances.

Apiam Animal Health Limited shareholders are set to vote on a scheme of arrangement offering $0.87 cash per share or a mix of cash and unlisted scrip in a new holding company controlled by Adamantem Capital. The Independent Expert deems the cash offer fair and reasonable, while scrip options carry liquidity and minority risks.

Assetora Limited has raised $1.535 million through three placements, including a second investment from Creative Capital Management, to advance its alternative-asset platform.